Mohammed Milhem
Clinical trials sponsored by Mohammed Milhem, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New triple-drug combo shows promise for advanced kidney cancer Results expected Dec 2026 (estimated)
-
Vitamin c boosts radiation for sarcoma? early trial shows promise
Disease control CompletedThis study tested whether giving high-dose vitamin C (ascorbate) alongside radiation therapy before surgery is safe and effective for people with advanced soft tissue sarcoma. 25 participants received vitamin C infusions three times a week during radiation. The goal was to see if…
Phase 1/2 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could selenium boost kidney cancer treatment?
Disease control CompletedThis trial tested a combination of two drugs—axitinib (a standard kidney cancer drug) and seleniomethionine (a form of selenium)—in 45 adults with advanced clear cell renal cell carcinoma that had spread. The goal was to find the safest dose and see if the combination could shrin…
Phase 1/2 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a 1950s antipsychotic help fight glioblastoma?
Disease control CompletedThis early-stage trial tested whether adding chlorpromazine, an old antipsychotic drug, to standard treatment (radiation and chemotherapy) is safe for people newly diagnosed with glioblastoma, an aggressive brain cancer. Ten adults took part. The main goal was to find a safe dose…
Phase 1 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Jun 26, 2026 13:07 UTC